NZ233646A - Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions - Google Patents
Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositionsInfo
- Publication number
- NZ233646A NZ233646A NZ23364690A NZ23364690A NZ233646A NZ 233646 A NZ233646 A NZ 233646A NZ 23364690 A NZ23364690 A NZ 23364690A NZ 23364690 A NZ23364690 A NZ 23364690A NZ 233646 A NZ233646 A NZ 233646A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dideoxy
- derivatives
- didehydro
- hydrates
- stable
- Prior art date
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35206589A | 1989-05-15 | 1989-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ233646A true NZ233646A (en) | 1991-10-25 |
Family
ID=23383649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ23364690A NZ233646A (en) | 1989-05-15 | 1990-05-11 | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JP2926257B2 (en) |
| CA (1) | CA2016765C (en) |
| CZ (1) | CZ9602347A3 (en) |
| DD (1) | DD298406A5 (en) |
| MY (1) | MY116824A (en) |
| NZ (1) | NZ233646A (en) |
| PL (1) | PL163999B1 (en) |
| SK (2) | SK237290A3 (en) |
| TW (1) | TW233301B (en) |
| YU (1) | YU92890A (en) |
| ZA (1) | ZA903662B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122207B2 (en) | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
| JP4731121B2 (en) * | 2004-02-02 | 2011-07-20 | 協和発酵キリン株式会社 | Xanthine derivative hydrate |
| JP5485138B2 (en) * | 2008-03-28 | 2014-05-07 | 浜理薬品工業株式会社 | Method for purifying ethynylthymidine compounds |
| EP2277878B1 (en) * | 2008-04-10 | 2014-09-17 | Hamari Chemicals, Ltd. | Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material |
-
1990
- 1990-05-11 YU YU92890A patent/YU92890A/en unknown
- 1990-05-11 NZ NZ23364690A patent/NZ233646A/en unknown
- 1990-05-12 TW TW79103864A patent/TW233301B/zh active
- 1990-05-14 ZA ZA903662A patent/ZA903662B/en unknown
- 1990-05-14 MY MYPI90000768A patent/MY116824A/en unknown
- 1990-05-14 PL PL28517590A patent/PL163999B1/en not_active IP Right Cessation
- 1990-05-14 CA CA002016765A patent/CA2016765C/en not_active Expired - Fee Related
- 1990-05-15 JP JP12326390A patent/JP2926257B2/en not_active Expired - Lifetime
- 1990-05-15 SK SK2372-90A patent/SK237290A3/en unknown
- 1990-05-15 DD DD90340679A patent/DD298406A5/en unknown
-
1996
- 1996-08-08 CZ CZ19962347A patent/CZ9602347A3/en not_active IP Right Cessation
-
1997
- 1997-09-19 SK SK1273-97A patent/SK127397A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2016765A1 (en) | 1990-11-15 |
| PL285175A1 (en) | 1991-01-14 |
| SK279130B6 (en) | 1998-07-08 |
| SK237290A3 (en) | 1998-07-08 |
| TW233301B (en) | 1994-11-01 |
| JPH035477A (en) | 1991-01-11 |
| CA2016765C (en) | 1997-10-21 |
| SK279253B6 (en) | 1998-08-05 |
| DD298406A5 (en) | 1992-02-20 |
| CZ288463B6 (en) | 2001-06-13 |
| CZ9602347A3 (en) | 2001-06-13 |
| PL163999B1 (en) | 1994-06-30 |
| SK127397A3 (en) | 1998-08-05 |
| YU92890A (en) | 1992-09-07 |
| MY116824A (en) | 2004-04-30 |
| JP2926257B2 (en) | 1999-07-28 |
| ZA903662B (en) | 1991-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL103571A0 (en) | Water soluble camptothecin derivatives,their preparation and pharmaceutical compositions containing them | |
| NZ226923A (en) | 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions | |
| GR3026225T3 (en) | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents | |
| IL128504A (en) | 2-HETEROARYL-N-PHENYL (ALKYL) THIENO [2,3-d] PYRIMIDIN-4-AMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| HUT49366A (en) | Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same | |
| NZ235726A (en) | Substituted pyrimidine derivatives; their preparation and pharmaceutical compositions | |
| NZ230144A (en) | Phosphorus-substituted purine derivatives and pharmaceutical compositions | |
| IL92293A0 (en) | 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives and pharmaceutical compositions containing them | |
| NZ227663A (en) | Purine nucleoside analogues, pyrimidine derivatives and pharmaceutical compositions | |
| NZ224189A (en) | 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions | |
| ZA907256B (en) | Low sodium salt composition | |
| IL98164A0 (en) | Antiviral nucleoside derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL66471A (en) | 9'-thiaergotaman-3',6',18-trione derivatives,their preparation and pharmaceutical compositions containing them | |
| JPS57144298A (en) | 7-beta-d-arabinofuranosyl-7h- pyrrolo(2,3-d)pyrimidine compound and manufacture | |
| AU7579291A (en) | Use of purinergic receptor agonists as antineoplastic agents | |
| IL95870A0 (en) | Purine nucleoside derivatives,their preparation and pharmaceutical compositions containing them | |
| IL98812A0 (en) | Purine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| DK630589D0 (en) | 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION | |
| NZ233646A (en) | Water soluble, stable, sodium salts of 2',3'-dideoxy-2',3'-didehydro thymidine derivatives, 2',3'-dideoxy inosine and 2'-fluoro derivatives in the form of hydrates; pharmaceutical compositions | |
| IL88138A0 (en) | Purine derivatives,their preparation and pharmaceutical compositions containing them | |
| NZ223865A (en) | 3'-azido or fluoro-2',3'-dideoxyribofuranosyl derivatives and pharmaceutical compositions therefrom | |
| NZ219250A (en) | Purine derivatives and pharmaceutical compositions | |
| IL109470A0 (en) | Water soluble camptothecin derivatives, their preparation and pharmaceutical compositions containing them | |
| NZ237442A (en) | 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions | |
| IL90567A0 (en) | Nucleoside derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |